Category

• Pipeline1
• Products1
• Research1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Clinical Trials3
• Dry Eye3
• Dry Eye Disease3
• Products3
• Eye Drop Solution2
• Eye Drops2
• Glance Videos1
• Artificial Tears1

• Organizations: Sun Pharma✕

Clear all

Research

Cequa's Onset of Action Trial demonstrates rapid ocular surface benefits

Recent data on the FDA-approved, preservative-free eye drop builds on supporting clinical findings—this time for DED patients preparing for refractive-cataract surgery.

Pipeline

Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED

Latest findings among patients switching from Restasis indicate significant improvements in total corneal staining and visual acuity.

Products

Phase 4 data on Cequa indicates significant DED improvements

New efficacy findings are the first in a series examining the FDA-approved formulation for chronic dry eye.